FDA Logo--links to FDA home page
U.S. Food and Drug Administration
HHS Log--links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizonal rule

FDA Talk Paper

T04-22
July 7, 2004

Media Inquiries: 301-827-6242
Consumer Inquiries: 888-INFO-FDA


FDA Seizes Adulterated Crabmeat in Louisiana
Product Contains Chloramphenicol and Poses Unacceptable Risk

This is a revised version of FDA Talk Paper T04-22, originally issued July 7, 2004. Revisions have been made to include the lot number and sell by date.

At the request of the Food and Drug Administration (FDA), U.S. Marshals seized approximately 1,144 cases of Bernard's brand frozen crabmeat, while it was being held for sale at Southern Cold Storage Company, Baton Rouge, La, on July 2, 2004 because it was adulterated with an unapproved food additive, chloramphenicol.

The U.S. Marshals seized approximately 304 cases of pasteurized special white crabmeat; 200 cases of pasteurized special claw crabmeat; and 640 cases pasteurized jumbo lump crabmeat. Imported from China, the frozen crabmeat can be identified by lot number 1302 with the sell by date of January 18, 2007. The seized crabmeat has an estimated value of $86,944.

In accordance with the Federal Food, Drug and Cosmetic Act, food products that contain chloramphenicol are adulterated and are not permitted to be sold in or imported into this country.

Chloramphenicol is a broad-spectrum antibiotic drug used to treat life-threatening infections in humans, usually when other alternatives are not available. The use of this antibiotic is limited because of its potentially life-threatening side effect, idiosyncratic aplastic anemia. For the very small number of the population susceptible to this side effect, exposure to chloramphenicol could be serious or life threatening. Because of the current uncertainty regarding the dose-response relationship between chloramphenicol ingestion and aplastic anemia, it is not possible to define a safe level for the presence of this antibiotic in food products.

In June 2002, FDA announced increased sampling of imported seafood for the presence of chloramphenicol. This action was taken because some states and other countries detected low levels of chloramphenicol in imported shrimp and crayfish.

The agency will continue to detain or seize any food imports that contain chloramphenicol to ensure that this product is not released for human or animal consumption in the United States.

###

rule